Asimov

Asimov is a Boston-based biotechnology company that develops computational tools and platforms for synthetic biology, enabling genetic designers to program living cells using software automation. The organization integrates laboratory-based synthetic biology with advanced design automation to construct complex biological systems, offering specialized bio-programming toolkits and design services to customers across the biotechnology sector. Operating at the intersection of software engineering and genetic engineering, the firm partners with researchers and commercial enterprises to accelerate the development of novel biological technologies. To support its operations, the enterprise has raised $4.7 million in seed funding from prominent backers including Andreessen Horowitz and the Defense Advanced Research Projects Agency (DARPA). Additionally, the company acquired the MIT-Broad Foundry to further enhance its internal research and development capabilities. Asimov was founded in 2017 by Alec Nielsen, Chris Voigt, Doug Densmore, and Raja Srinivas.